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 A full life cycle (parr to harvest) study of growth and performance was conducted in Atlantic salmon 17 
fed diets high in plant ingredients supplemented with graded levels of a nutrient premix (NP), 18 
containing selected amino acids, taurine, cholesterol, vitamins and minerals to re-evaluate current 19 
nutrient recommendations. Triplicate groups were fed one of three NP levels included at 1x, 2x and 20 
4x, where 1x corresponds to recommendations of NRC (2011). Whole body and specific tissue 21 
concentrations of nutrients were monitored throughout the experiment as requirement markers. 22 
Growth in parr was significantly enhanced in 2xNP, but restricted in 4xNP, while in post-smolts 23 
growth was positively correlated with NP level. Spinal deformity decreased linearly with increased 24 
NP level in both smolt and post-smolts. When fishmeal and fish oil are present at very low levels, as 25 
in the present study, we found beneficial effects with moderate increased levels of the B-vitamins 26 
niacin, riboflavin and cobalamin. Further, vitamin C should be increased, based on metabolic 27 
responses, although it did not influence growth.  Increased Zn and Se affected fish metabolism in a 28 
positive manner.  Alterations in hepatic transcriptome profiles and expression of specific genes of 29 
metabolic pathways were evident in response to micronutrient supplementation level. Collectively, 30 
increasing the levels of the micro-nutrient package to a too high level, showed a negative effect and 31 
cannot be recommended. NRC (2011) recommendations should therefore be revised for diets in which 32 
plant ingredients form the major part of the formulation.   33 
 34 
Keywords: Fishmeal, fish oil, plant proteins, vegetable oil, vitamins, minerals, skeletal deformity, 35 
sustainable feeds.  36 
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1. Introduction 37 
Over the last decade and a half, feed formulations for farmed Atlantic salmon (Salmo salar) have 38 
changed with marine raw materials, fish oil (FO) and fishmeal (FM), being increasingly replaced by 39 
high levels of plant ingredients (Gatlin III et al., 2007; Hardy, 2010; Turchini et al., 2011). Levels of 40 
marine ingredients, FM and FO, in salmon feeds are now approximately 20 % of total feed inclusion 41 
compared with 90 % around 20 years ago (Ytrestøyl et al., 2015). Over this period, many studies 42 
investigated the effects of the inclusion of plant-derived ingredients in feeds. The majority of studies 43 
focussed on the impacts on growth performance and feed utilisation (Torstensen et al., 2000; Opstvedt 44 
et al., 2003; Mundheim et al., 2004; Espe et al., 2006; Torstensen et al., 2005; Pratoomyot et al., 2008; 45 
Waagbø et al., 2013), and also on product quality for human consumers (Waagbø et al., 1993; 46 
Mundheim et al., 2004; Torstensen et al., 2005; Menoyo et al., 2007). However, overall, the 47 
development and application of modern, plant-based feed formulations has been largely successful 48 
enabling salmon production to be maintained and/or increased despite the finite and limited supplies 49 
of FM and FO (Shepherd & Jackson, 2013). 50 
Despite the above, formulating salmon feeds with high levels of plant meals and vegetable 51 
oils significantly affects a range of nutrients (Sissener et al., 2013), including changing micronutrient 52 
concentrations and their chemical forms, as well as introducing compounds that interact with 53 
micronutrient uptake and metabolism (Olsvik et al., 2013). Importantly, in addition to affecting fish 54 
growth, feed efficiency and product quality, these changes in nutrient composition could also affect 55 
fish health and welfare (Oxley et al., 2005; Seierstad et al., 2005; Waagbø, 2006; Hemre & Sandnes, 56 
2008; Waagbø, 2008; Seierstad et al., 2009). As a result, there has been increasing interest in 57 
improving knowledge of practical nutrient requirements of Atlantic salmon when fed modern, plant 58 
based feeds (Hansen et al., 2015). In particular, there has been a focus on micronutrients (minerals, 59 
vitamins etc.) as it is believed that these were likely supplied in surplus in feeds containing high levels 60 
of FM and FO, and that levels of some micronutrients in terrestrial raw materials can be lower 61 
(Sissener et al., 2013). When feeding plant-based diets enriched with the micronutrients folate, 62 
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vitamin B12, vitamin B6, methionine and choline to zebrafish (Danio rerio) over the entire life cycle, 63 
fish responded with increased growth, higher fecundity and altered metabolic profile of several N-64 
metabolites, indicating an overall positive effect of a micronutrient-enriched plant-based diet 65 
(Skjaerven et al., 2016). As a consequence, micronutrient and mineral requirements need careful re-66 
evaluation when substituting raw materials, as the current established micronutrient supplements / 67 
premixes (National Research Council, NRC 2011) may not be sufficient to satisfy requirements for 68 
Atlantic salmon, especially throughout the whole life cycle.  69 
To investigate this, micronutrient requirements of Atlantic salmon fed diets formulated with 70 
high levels of plant meals and vegetable oil were studied in two regression experiments in parr in 71 
freshwater and post-smolts in seawater (Hamre et al., 2016; Hemre et al., 2016; Prabhu et al. 2019a). 72 
A nutrient package, consisting of vitamins B, C, D3, E, minerals, cholesterol, taurine and histidine 73 
was fed at various levels from below NRC (2011) recommended levels to well above NRC levels. 74 
Growth, health and welfare parameters responded to nutrient packages in parr, but not to the same 75 
extent in post-smolts (Hemre et al., 2016). Thus, parr fed diets containing the nutrient package 76 
supplying micronutrients above NRC (2011) recommended levels showed improved protein retention, 77 
and reduced liver and viscera indices, whereas the response was less pronounced in post-smolt 78 
(Hemre et al., 2016). Significant regressions were obtained in body compartments for vitamin C and 79 
several of the B-vitamins and, based on these results, the authors recommended that B-vitamin 80 
supplements should be adjusted in plant-based diets for Atlantic salmon (Hamre et al., 2016; Hemre 81 
et al., 2016). There were no indications of vitamin E deficiency when vitamin E was not supplemented, 82 
indicating that the ingredients delivered sufficient amounts of vitamin E. Nevertheless, it was 83 
recommended to supplement 150 mg kg-1vitamin E to compensate in periods of oxidative stress 84 
(Hamre et al., 2016). Regarding the micro-minerals, requirements of Atlantic salmon fed the plant-85 
based diet were met at NP inclusion of 100-150 % and 150-200 % in parr and post-smolt, respectively 86 
(Prabhu et al., 2019a).  87 
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More recently, the impact of micronutrients was investigated in both diploid and triploid 88 
Atlantic salmon parr fed graded levels of a nutrient package (NP) from around 30 g to seawater 89 
transfer (Taylor et al., 2019). The diets were formulated with very low levels of marine ingredients 90 
and supplemented with three levels of NP (L1, 100 %; L2, 200 % and L3, 400 % NP), which contained 91 
24 micronutrients including selected amino acids, vitamins, minerals, taurine and cholesterol. The 92 
NP was based on the minimum nutrient recommendations for Atlantic salmon (NRC, 2011). Diploid 93 
parr fed L2 showed significantly improved growth and reduced liver (HSI) and viscera (VSI) indices, 94 
and hepatic steatosis, compared to fish fed L1, while diploids fed L3 also showed improved growth 95 
in the first 14 weeks, although growth rate was subsequently reduced (Taylor et al., 2019). In contrast, 96 
dietary NP level had less effect on triploid growth rate, VSI or HSI, and smoltification was not 97 
affected by NP in either ploidy. Overall, results suggested that, while micromineral requirements 98 
were met, other micronutrients may require to be supplemented above current NRC (2011) 99 
recommendations for optimal growth and liver function of diploid Atlantic salmon fed plant-based 100 
diets in freshwater (Taylor et al., 2019). In addition, the above study also investigated the impact of 101 
NP level on skeletal deformity and bone health including the prevalence, localisation and pathology 102 
of spinal malformation, and vertebral expression of bone biomarker genes (Vera et al., 2019). This 103 
study showed that prevalence of radiologically detectable spinal deformities decreased with 104 
increasing micronutrient supplementation when fed from parr to smolt. Concomitantly, expression of 105 
many osteogenic genes (bone morphogenic protein, osteocalcin, alkaline phosphatase, matrix 106 
metallopeptidase, insulin-like growth factor) increased with increasing NP inclusion. The 107 
observations suggested that components thereof, or interactions between micronutrients within the 108 
NP may be affecting downstream processes involved in bone formation and remodelling, which also 109 
occur through active epigenetic regulatory mechanisms of gene expression (Saito et al., unpublished 110 
data). 111 
The previous trials investigating dietary micronutrients in salmon were all carried out during 112 
the freshwater phase other than one short-term (5-month) trial in post-smolt in seawater (Hamre et 113 
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al., 2016; Hemre et al., 2016; Taylor et al., 2019; Vera et al., 2019; Prabhu, et al., 2019a). Therefore, 114 
the aim of the present study was to determine the influence of micronutrients in Atlantic salmon fed 115 
diets formulated with very low levels of marine ingredients over the entire life cycle. To this end, 116 
diploid Atlantic salmon were fed from around 30 g to 3 Kg with plant-based feeds supplemented with 117 
the same NP as described above to produce three experimental diets (L1, 100 %; L2, 200 % and L3, 118 
400 % NP). The impacts of NP levels on growth, feed efficiency, nutrient retention, skeletal 119 
development and liver gene expression were determined. 120 
 121 
2. Methods & Materials 122 
2.1 Fish and feeds 123 
The trial was carried out with Atlantic salmon obtained from SalmoBreed AS (Norway). All 124 
experimental procedures and husbandry practices were conducted in compliance with the Animals 125 
Scientific Procedures Act 1986 (Home Office Code of Practice) in accordance with EU regulation 126 
(EC Directive 86/609/EEC) and approved by the Animal Welfare and Ethical Review Board 127 
(AWERB) of the University of Stirling. All fish were monitored daily by the Named Animal Care 128 
and Welfare Officer (NACWO). 129 
Feeds were formulated to reflect standard practice in commercial salmon feeds in terms of 130 
protein, oil and energy contents. Thus, feeds were initially formulated to contain 48 % protein and 131 
20 % lipid (~22 MJ), with protein content decreasing and lipid content increasing with increasing 132 
pellet size to reach 36 % protein and 34 % lipid (~24 MJ) in the largest pellet size in seawater. The 133 
experimental feeds were a low FM/FO formulation (initially 15 % and 8 % in freshwater, decreasing 134 
to 5% and 3 % respectively in seawater, Tables 1 & 2). Feeds were supplemented with a nutrient 135 
package (NP, Tables 3 and 4) at one of three inclusion levels to produce 3 dietary treatments: L1, 136 
100 % NP; L2, 200 % NP; L3, 400 % NP (Table 4), the assumption being that the 100 % NP package 137 
should contain 100 % of assumed requirement based on the levels reported for Atlantic salmon at the 138 
time (NRC, 2011). Specifically, the NP contained 24 nutrients in total these being; vitamins (A, D3, 139 
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E, K3, C, thiamine, riboflavin, B6, B12, niacin, pantothenic acid, folic acid and biotin), minerals (Ca, 140 
Co, I, Se, Fe, Mn, Cu and Zn), crystalline amino acids (L-histidine and taurine) and cholesterol. Total 141 
and available phosphorus were fixed in all diets at 12.0 and 9.0 g kg-1 respectively, and magnesium 142 
at 1.5 g kg-1, and were not part of the NP. Pellet size (2 mm, 3.5 mm, 5 mm, 7 mm, 9 mm) was 143 
adjusted according to fish weight. All non-oil ingredients were mixed and pellets produced by 144 
extrusion to produce three base pellets that had oil added by vacuum coating. All feeds were produced 145 
at the BioMar Tech-Centre (Brande, Denmark). 146 
 147 
2.2 Feeding trial 148 
The freshwater phase was carried out at the Niall Bromage Freshwater Research Facility (Stirlingshire, 149 
UK). Initially, 500 diploid salmon pre-smolt (initial mean weight, 38.2 ± 0.6 g) were stocked (2 Sept-150 
14) into nine x 1.6 m3 circular fibreglass tanks (3 tanks / diet, initial stocking density 12.0 ±  0.1 kg 151 
m-3). Fish were acclimated to the experimental tanks for 2 weeks (Fed BioMar Inico Plus)  before 152 
being fed the experimental diets. Fish were fed continuously during the light period of the light:dark 153 
cycle by automatic feeders (Arvotec T2000, Arvotec, Finland) controlled by a PC system. Specific 154 
feeding rates (SFR; % tank biomass per day) were adjusted automatically according to predicted 155 
growth and daily temperature. An out-of-season photoperiod (LL – 400 °days LD14:10 – 400 °days 156 
LL) and ambient water temperature (12 - 16 ˚C) was applied to produce S0+ smolts (final stocking 157 
density 20.2 – 22.8  kg m-3), with lighting provided by two 28 W fluorescent daylight bulbs (4000 °K; 158 
RS Components, UK) mounted centrally within the tank lid. Water was supplied by an upstream 159 
reservoir under flow-through conditions (10 L min-1). Oxygen levels were always higher than 8 mg 160 
L-1. Uneaten feed recovery was not feasible during the freshwater phase. 161 
Smolts were transferred (4 Nov-14) to the Marine Harvest (Mowi) Feed Trial Unit (Ardnish, 162 
Scotland) and on-grown for 11 months in nine 5x5x5 m sea pens  under natural photoperiod and 163 
ambient water temperatures ranging from 6 to 16 ˚C. Triplicate groups of 250 post-smolts from 164 
respective tanks were stocked per pen (Initial stocking density 0.17 – 0.19  kg m-3) and on-grown to 165 
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a final size of ~2.5 Kg (15 Sept-15, Final stocking density 4.52 – 5.18  kg m-3). Fish were fed 166 
continuously during daylight by automatic feeders (Arvotec T2000) controlled by a PC system. 167 
Specific feeding rates (SFR; % pen biomass per day) were adjusted weekly according to predicted 168 
growth and water temperature. Waste feed was collected per pen by means of air uplifts following 169 
meal delivery ensuring satiation and allowing calculation of total daily feed intake. 170 
 171 
2.3 Growth and feed efficiency 172 
Fish were sampled at start and end of the freshwater phase, and then at approximately 250 g, 500 g, 173 
1 kg, and ~2.5 kg in seawater prior to dietary pellet size/formulation changes. In freshwater at each 174 
sampling point, 50 fish / tank were anaesthetised (50ppm Tricaine, PHARMAQ, UK), individual 175 
weights (± 0.1 g) and fork lengths (± 1.0 mm) measured, while in seawater, all fish per pen were 176 
counted and individually measured. Following measurement, all fish were allowed to recover in 177 
aerated water before returning to their original experimental tanks/pens. Fulton’s condition factor (K) 178 
was calculated using: K = (WL−3)100; where W is body weight (g) and L is fork length (mm). Weight 179 
data were used to calculate specific growth rate (SGRwt), thermal growth coefficient (TGC) and feed 180 
conversion rate (FCR) for each sampling period where SGRwt was calculated as: (eg−1)×100, where 181 
g = (ln(Wf) − ln(Wi)) × (t2−t1)
−1 and TGC was calculated as: (Wf1/3-Wi1/3) x (∑Do)-1, where Wf is the 182 
final body weight, Wi is the initial body weight and Do is the cumulative sum of water temperature in 183 
degrees per day. FCR was calculated as: Fi / (Bf−Bi+Bm) where Fi is the fed intake (kg), Bf is the final 184 
biomass (kg), Bi is the initial biomass (kg) and Bm is the mortality biomass for the period (kg). 185 
Maturation at harvest was determined by assessment of external appearance of secondary sexual 186 
characteristics and gonad development (n = 30 / pen), where gonadosomatic-index (GSI) was 187 
calculated as GSI (%) = (GW×100)/BW. Fish were classified as sexually recruited based on a threshold 188 
value of GSI >0.20 % or >1.0 % for males and females respectively (Kadri et al., 1997). 189 
 190 
2.4 Biochemical composition and nutrient retention 191 
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At the termination of the trial, 10 fish per pen (30 / diet) were euthanised using lethal anaesthesia 192 
(>200 mg L-1 Tricaine, PHARMAQ UK) to provide samples for biochemical analyses. Five whole 193 
fish per pen (15 / diet, in 3 pen pools, n = 3) were taken for the determination of proximate 194 
composition (MOPA), minerals, and fatty acid composition. In addition, muscle/flesh (Norwegian 195 
Quality Cut, NQC) were collected from 5 additional fish per pen (15 fish/diet in 3 pen pools, n = 3) 196 
for MOPA, minerals, carotenoid (flesh), fatty acid composition, and total amino acid. 197 
 198 
2.4.1. Proximate composition 199 
Whole fish and diets were ground before determination of proximate composition according to 200 
standard procedures (AOAC, 2000). Five fish were pooled per pen and three technical replicates for 201 
the single batch feeds were analysed. Moisture contents were obtained after drying in an oven at 202 
110 °C for 24 h and ash content determined after incineration at 600 °C for 16 h. Crude protein content 203 
was measured by determining nitrogen content (N x 6.25) using automated Kjeldahl analysis (Tecator 204 
Kjeltec Auto 1030 analyzer, Foss, Warrington, UK) and crude lipid content determined 205 
gravimetrically after Soxhlet lipid extraction (Tecator Soxtec system 2050 Auto Extraction apparatus). 206 
 207 
2.4.2. Amino acid, mineral and vitamin analyses 208 
Free amino acids and nitrogen metabolites were analysed using the Biochrome with post-column 209 
derivatisation with ninhydrin as described by Espe et al. (2014). The total amino acids in whole body 210 
and diets were analysed after being hydrolysed in 6N HCl for 22 h as previously described (Espe et 211 
al., 2014) and used for calculation of amino acid retention (% deposited of consumed amino acid).  212 
The B-vitamins biotin, niacin, folate, pantothenic acid and cobalamin were all determined by 213 
microbiological methods as described in detail previously (Mæland et al., 2000; Feldsine et al., 2002). 214 
Some of the B-vitamins were determined by HPLC by standard methods; thiamine (CEN, 2003), 215 
vitamin B6 (CEN, 2006) and riboflavin (Brønstad et al., 2002). Multi-element determination was 216 
done by ICP-MS (inductively coupled plasma mass spectrometry) (Julshamn et al., 1999). HPLC was 217 
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used for determination of ascorbic acid (Mæland and Waagbø, 1999) and tocopherols were analysed 218 
according to standard methodology (CEN, 1999). Vitamins A and D were analysed according to 219 
Moren et al. (2004) and Horvli and Lie (1994), respectively. 220 
 221 
2.4.4. Lipid content and fatty acid composition 222 
Samples of whole bodies and NQC from five fish per tank were prepared as pooled pen homogenates 223 
(n = 3 per diet). Total lipid was extracted from approximately 1 g of sample by homogenising in 224 
chloroform/methanol (2:1, v/v) using an Ultra-Turrax tissue disrupter (Fisher Scientific, 225 
Loughborough, UK), and content determined gravimetrically (Folch et al., 1957). Fatty acid methyl 226 
esters (FAME) were prepared from total lipid by acid-catalysed transesterification at 50 °C for 16 h 227 
(Christie, 2003), and FAME extracted and purified as described previously (Tocher and Harvie, 1988). 228 
FAME were separated and quantified by gas-liquid chromatography using a Fisons GC-8160 229 
(Thermo Scientific, Milan, Italy) equipped with a 30 m × 0.32 mm i.d. × 0.25 μm ZB-wax column 230 
(Phenomenex, Cheshire, UK), on-column injector and a flame ionisation detector. Data were 231 
collected and processed using Chromcard for Windows (version 2.01; Thermoquest Italia S.p. A., 232 
Milan, Italy). Individual FAME were identified by comparison to known standards and published 233 
data (Tocher and Harvie, 1988). 234 
 235 
2.4.5. Pigment analysis 236 
Flesh carotenoid levels were determined using a modified version of the JX Nippon Oil Corporation’s 237 
Analytical methods for Panaferd-AX. Briefly, three grams of homogenised flesh samples were 238 
transferred to a 50 ml Quickfit tube. Measurements of the samples were done to two decimal places. 239 
One mL of deionised water was added to the tubes. Subsequently, 5 ml of tetrahydrofuran 240 
(THF)/methanol (20:1, v/v) were added and the mixture shaken vigorously for 1 min and then mixed 241 
using a shaker for 5 min. Ten millilitres of iso-hexane were then added and the contents mixed 242 
thoroughly before being centrifuged at 340 g for 10 min. The supernatant was transferred to a 50 ml 243 
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volumetric flask. Five mL of tetrahydrofuran (THF)/methanol (20:1, v/v) were added to the initial 244 
tube and the process repeated three times, making a pool of four extractions in the volumetric flask. 245 
Then, iso-hexane/THF/methanol (40:20:1, v/v/v) was added to the flask making up the volume of the 246 
pooled extractions to 50 ml. Subsequently, 10 ml of the samples were removed and evaporated to 247 
dryness under a nitrogen stream at room temperature, before being re-suspended in 2 ml isohexane 248 
prior to HPLC analysis. Samples were injected on a Thermo Scientific Ultimate 300 HPLC system 249 
equipped with a 150 x 4.6 mm 3µ Phenomenex silica column with detection at a wavelength of 474 250 
nm and a column temperature of 25 ˚C. The carotenoids were quantified using an external standard 251 
of astaxanthin obtained from DSM (Heerlen, Netherlands). 252 
 253 
2.5 Skeletal development and spinal deformity  254 
Skeletal development and spinal malformation in smolt and harvest fish was assessed by x-ray 255 
radiography. Twenty-five fish per tank/pen (n = 3) were euthanised using lethal anaesthesia (>200 256 
mg L-1 Tricaine, PHARMAQ UK), placed on flat trays and frozen at -20 ̊ C prior to x-ray radiography. 257 
Frozen fish were x-radiographed using a portable x-ray unit (Celtic SMR PX40 HF) with an 258 
extremities plate measuring 24 x 30 cm. Each radiograph was exposed for 32 mAs and 40kV and the 259 
image digitised (AGFA CR-35X).  Radiographs were analysed using Adobe Photoshop CS 6 (version 260 
13.0.1, Adobe system Incorporated, California, USA) with the spine divided into four regions, R1, 2, 261 
3, and 4 as per Kacem et al. (1998) and deformity type categorised according to Witten et al. (2009). 262 
Example pathologies were provided previously (Vera et al., 2019). Observations were made in the 263 
anterior-caudal direction and the total number of vertebra was recorded for each fish.  264 
 265 
2.6 Gene expression  266 
At the termination of the trial, a further 5 fish per pen were euthanised using lethal anaesthesia (>200 267 
mg L-1 Tricaine, PHARMAQ UK) to provide samples for molecular analyses. Liver and muscle 268 
samples were aseptically dissected and placed in microcentrifuge tubes containing RNA-later for the 269 
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assessment of gene expression using microarray (liver transcriptome) and targeted gene expression 270 
through the application of real-time qPCR analysis of liver and muscle. The tissue samples were 271 
homogenised in 1 mL of TRIzol® (Invitrogen, UK) and total RNA extracted in accordance with the 272 
manufacturer’s instructions. RNA pellets were rehydrated in MilliQ water, and total RNA 273 
concentration determined using an ND-1000 Nanodrop spectrophotometer (Labtech Int., East Sussex, 274 
UK), and RNA integrity assessed by electrophoresis. 275 
 276 
2.6.1. Transcriptomic (microarray) analysis 277 
Transcriptome analysis of liver (male only) was performed using an Atlantic salmon custom-made 278 
oligoarray with 44 k features per array in a four-array-per-slide format (Agilent Technologies UK 279 
Ltd., Wokingham, UK). A dual-label experimental design was used for the microarray hybridisations 280 
with Cy3-labelled test samples competitively hybridised to a common Cy5-labelled pooled-reference 281 
per array. A total of 15 arrays were employed, one array per individual fish. The common reference 282 
was a pool of equal amounts of amplified RNA from all test samples. Indirect labelling was employed 283 
in preparing the microarray targets. Amplified antisense RNA (aRNA) was produced from each RNA 284 
sample using TargetAmpTM 1-Round Aminoallyl-aRNA Amplification Kit 101 (Epicentre, Madison, 285 
Wisconsin, USA), as per manufacturer’s methodology, followed by Cy3 or Cy5 fluor (PA23001 or 286 
PA25001, GE HealthCare) incorporation through a dye-coupling reaction, as described by Betancor 287 
et al. (2016). The hybridisations were performed using SureHyb hybridisation chambers (Agilent) in 288 
a DNA Microarray Hybridisation Oven (Agilent). Sample order was semi-randomised, with one 289 
replicate per experimental group being loaded into each slide. For each hybridisation, 825 ng of Cy3-290 
labelled experimental biological replicate and Cy5-labelled reference pool were combined, following 291 
the protocol described by Morais et al. (2012). 292 
 293 
2.6.2. Quantitative Real Time PCR  294 
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cDNA was reverse transcribed from 1 µg of total liver or muscle RNA using QuantiTect Reverse 295 
Transcription kit (Qiagen Ltd., Manchester, UK). The resulting cDNA was diluted 20-fold with 296 
milliQ water. Real-time PCR was performed using Luminaris color Higreen qPCR Master mix 297 
(Thermo Fisher Scientific, MA, USA) and Mastercycler RealPlex 2 thermocycler (Eppendorf, UK) 298 
which was programmed to perform the following protocol: 50 ºC for 2 min, 95 ºC for 1 min, followed 299 
by 40 cycles at 95 ºC for 15 s, annealing temperature (see Additional File 1) for 15 s and 72 ºC for 300 
30s. This was followed by a temperature ramp from 70 to 90 ºC for melt-curve analysis to verify that 301 
no primer-dimer artefacts were present and only one product was generated from each qPCR assay. 302 
qPCR was performed in 96-well plates in duplicates per sample. The final volume of the PCR reaction 303 
was 10 µL: 2.5 µL of cDNA, 5 µL of the qPCR Master Mix and 2.5 µL of forward and reverse primers. 304 
The efficiency of the primers was verified and validated by doing standard curves for all genes 305 
investigated. The new primers used in this study were designed using the software PRIMER3 306 
(Untergasser et al., 2012). Target specificity was checked in silico using Blast (NCBI). Only primer 307 
pairs with no unintended targets were selected (Additional File 1). The relative expression of target 308 
genes in liver and muscle of salmon post-smolts was calculated by the ΔΔCt method (Pfaffl, 2001), 309 
using β-actin, ef1a, polr2f and rpl1 as the reference genes, which were chosen as the most stable 310 
according to RefFinder (Xie et al., 2012). 311 
In liver, the genes investigated were involved in sterol metabolism (apolipoprotein B, acetyl-312 
CoA carboxylase and cholesterol 7 alpha-hydroxylase), long-chain polyunsaturated fatty acid (LC-313 
PUFA) metabolism (fatty acyl elongase 2, fatty acyl elongase 5 isoform b, fatty acyl elongase 6 and 314 
delta-6 fatty acyl desaturase isoform a), immune system (interleukin 8, interleukin 1 beta, major 315 
histocompatibility complex I and fas cell surface death receptor), 1-carbon metabolism 316 
(cystathionine-β-synthase, betaine-homocysteine S-methyltransferase, methionine 317 
adenosyltransferase1) and growth hormone receptor. In muscle, the expression levels of genes 318 
involved in protein and energy metabolism (glucose transporter type 4, muscle-specific RING finger 319 
protein 1a, muscle-specific RING finger protein 1b, autophagy-related protein 4 homolog B, 320 
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autophagy related  12, microtubule-associated proteins 1A/1B light chain 3B precursor and GABA(A) 321 
receptor-associated protein), immune function (interleukin 1 beta) and growth (growth hormone 322 
receptor and insulin-like growth factor) were studied.  323 
 324 
2.7 Statistical analysis 325 
Growth and biochemical data were presented as means ± SD and analysed using one-way analysis of 326 
variance (ANOVA), general linear model, and pairwise comparison (Tukey) of means. Data were 327 
checked for homogeneity of the variances by the Bartlett test and, where necessary, the data were 328 
transformed (arcsine or ln) for normalisation before further statistical analysis. Statistical tests were 329 
performed using Minitab statistical software (Version 17©, University of Stirling, 2016). Data on 330 
vitamins, minerals, free and hydrolysed amino acids were analysed using Statistica (ver13.4, Sibco 331 
software inc.) by one way ANOVA and Tukey’s post-hoc test when variances were homogenous, 332 
otherwise with the Kruskal-Wallis ANOVA by Ranks. Differences were considered statistically 333 
significant at p values < 0.05. Statistical analysis of microarray data was performed in GeneSpring 334 
GX (Agilent Technologies, Wokingham, Berkshire, UK) using a Moderated t-test, at 0.05 335 
significance. Data were submitted to the Kyoto Encyclopedia of Genes and Genomes (KEGG; 336 
Kanehisa and Goto, 2000) for biological function analysis. The significance of differences in RT-337 
qPCR data between dietary groups was determined using a one-way ANOVA followed by Tukey’s 338 
test, using SPSS v.19 software (IBM, Armonk, NY), with significance level fixed at p < 0.05.  339 
   340 
3. Results 341 
3.1 Mortality, growth and maturation 342 
There were no significant differences in cumulative mortality between dietary treatments in 343 
freshwater or seawater (Table 5). Diet had a significant effect on weight, growth rate (TGCwt) and 344 
bFCR in both freshwater and saltwater (Fig. 1, Table 5). Fish fed diet L2 achieved the highest final 345 
smolt weight, with fish fed diet L1 significantly lower, and diet L3 intermediary to both. This pattern 346 
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was mirrored by similar significant dietary effects on TGCwt and bFCR. Final smolt K factor 347 
decreased with increasing NP inclusion level. Diet did not significantly affect VSI, while HSI was 348 
significantly lower in salmon fed diets L2 and L3 than fish fed diet L1 at smolt. 349 
In seawater, fish fed diets L2 and L3 achieved a significantly higher final weight than those 350 
fed diet L1, but did not differ significantly between each other. Moreover, a trend was clearly evident 351 
in TGCwt, which increased with increasing NP inclusion level (Table 5). In particular, salmon fed diet 352 
L3 were transferred to sea at a significantly lower smolt weight than those fed diet L2, but achieved 353 
a comparable body weight to fish fed diet L2 within 4 months of seawater transfer (Fig. 1). Final K 354 
factor also showed a significant increase with increasing dietary NP inclusion level, and bFCR was 355 
significantly lower in fish fed diets L2 and L3 than diet L1. Both VSI and HSI were not significantly 356 
different at harvest between diets, and no statistical differences in maturation rates (predominantly 357 
males), were observed between fish fed the different diets. 358 
 359 
3.2 Radiological deformity  360 
Externally visible malformation was <1 % at the end of both freshwater and seawater phases, but 361 
radiologically detected spinal deformity was significantly affected by diet (Fig. 2). There was a 362 
progressive reduction in detectable malformation in fish with increasing NP inclusion level. At smolt, 363 
fish fed diet L3 had significantly lower detectable deformity than fish fed diet L1, and diet L2 was 364 
intermediary to both. The predominant region affected with spinal malformation was in the caudal 365 
trunk region (R2), with v24-28 the most commonly affected vertebral bodies. At the end of the 366 
seawater phase, there was an increase, albeit non-significant, in detectable deformity in fish fed diets 367 
L1 and L2 to that observed at smolt, and the pattern was maintained whereby salmon fed diet L3 had 368 
significantly lower deformity than those fed diet L1, and diet L2 was intermediary to both. The 369 
predominant region affected with spinal malformation was in the tail region (R3), posterior to the 370 
dorsal fin, with v38 - 44 the most commonly affected vertebral bodies. Most deformities presented 371 
themselves as compressive type pathologies (~53 % of total pathology) followed by reduction in 372 
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intervertebral spacing (~30 %) and, finally, more severe, fusion-type lesions (~15 %), and was 373 
generally similar across all diets. 374 
 375 
3.3 Whole body composition and nutrient retention 376 
Post-smolts had similar whole body composition independent of dietary NP inclusion level, with the 377 
exception of whole body ash that was significantly higher in salmon fed diet L3 than those fed diets 378 
L1 or L2. Whole body Zn and Se concentration increased significantly with increasing NP inclusion 379 
(Table 6). Retention of Cu decreased with increased NP inclusion, while Se retention was 380 
significantly higher in L3 than both L1 and L2. Remaining nutrient retentions did not differ between 381 
fish fed the different diets. NQC composition was generally comparable between diets, however there 382 
was a significantly higher total lipid in fish fed diet L3 than those fed diets L1 or L2. As a percentage 383 
of total fatty acids, n-6 long-chain polyunsaturated fatty acids (LC-PUFA) and docosahexaenoic acid 384 
(DHA; 22:6n-3) decreased with increasing NP inclusion level 385 
 386 
3.4 Total amino acid concentration in whole body and free amino acids and N-metabolites in 387 
white muscle tissue 388 
Whole body histidine and lysine retention decreased with increasing NP inclusion level, while all 389 
other amino acid retentions were similar between fish fed the different diets (Table 7). Muscle content 390 
of free OH-Pro, serine and glycine significantly decreased with increasing NP inclusion, while free 391 
histidine, increased significantly with NP inclusion level (Table 8). 392 
 393 
3.5 Tissue water soluble vitamin status and retention 394 
Vitamin C showed higher concentrations in whole body of fish fed L2 and L3 than in those fed L1. 395 
Vitamin C concentration in liver was not significantly different between fish fed the three diets, but 396 
the trend was that vitamin C increased from L1 to L2 and then decreased again in fish fed L3. Whole 397 
body pantothenic acid and niacin increased significantly with increasing NP inclusion, while 398 
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concentrations of the other B-vitamins in whole body were comparably independent of dietary NP 399 
inclusion level (Table 9).  Riboflavin retention and the retention of folate decreased significantly with 400 
increasing NP inclusion, while thiamine, niacin and biotin showed no significant effect of NP 401 
inclusion. Tissue specific concentrations (liver, gill and muscle) of the measured B-vitamins were 402 
comparable and independent of dietary NP inclusion level, although there was a trend for increasing 403 
gill pantothenic acid and muscle vitamin B6 concentration with increasing NP inclusion. 404 
 405 
3.6 Tissue lipid soluble vitamin status and retention 406 
With the exception of vitamin K1 and γ-TOH (tocopherol), all other lipid soluble vitamins in whole 407 
body and tissue (liver and muscle) showed a significant increase in concentration with increasing NP 408 
inclusion level (Table 10). Whole body α-TOH retention increased with NP inclusion level. 409 
 410 
3.7 Gene expression 411 
3.7.1 Liver transcriptome 412 
Transcriptome analysis was performed on liver tissue in individual male fish (n = 5). Statistical 413 
analysis of the microarray data returned a list of 306 and 360 annotated differentially expressed genes 414 
(DEG) in liver of salmon fed the L2 and L3 diets, respectively, when compared to fish fed diet L1 415 
(moderated t-test, p < 0.05 and fold-change > 1.3). In addition, a total of 396 genes were differentially 416 
expressed (fold-change > 1.3) in the liver of salmon fed diet L3 when compared to fish fed diet L2. 417 
Functional analysis for all contrasts (Kyoto Encyclopedia of Genes and Genomes, [KEGG] 418 
Orthology) showed a similar distribution by categories of DEG, with the major categories being 419 
metabolism, signal transduction and immune system. Within metabolism, the most represented 420 
category was lipid metabolism in all cases (Fig. 3). Pathway analysis showed that the top significant 421 
differentially expressed pathways in the L2 vs. L1 comparison were: PI3K-Akt signalling pathway, 422 
protein processing in endoplasmic reticulum, steroid biosynthesis, sphingolipid signalling pathway, 423 
phagosome and focal adhesion (Additional File 2). Moreover, the most represented metabolic 424 
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pathways suggested a downregulation of lipid metabolism (steroid biosynthesis, sphingolipid 425 
metabolism, glycerophospholipid metabolism, glycerolipid metabolism and arachidonic acid 426 
metabolism) in fish fed diet L2 compared to the L1 diet (Fig. 4A, Additional File 3). Regarding the 427 
L3/L1 contrast, the top significant differentially expressed pathways were PI3K-Akt signalling 428 
pathway, regulation of actin cytoskeleton, MAPK signalling pathway, Rap1 signalling pathway, NF-429 
kappa B signalling pathway, focal adhesion and chemokine signalling pathway (Additional File 4). 430 
In this case, most genes involved in lipid and amino acid metabolism were downregulated whereas 431 
oxidative phosphorylation and glycolysis were upregulated (Fig. 4B, Additional File 3).  432 
In order to identify common functional categories affected by micronutrient supplementation 433 
results from each pairwise contrast were intersected, obtaining a list of 138 common features 434 
corresponding to a total of 58 annotated genes. The most affected biological categories for L3/L1 435 
were metabolism (27 %), signal transduction (15 %), immune system (9 %) and endocrine system 436 
(8 %). Within metabolism the most represented category was lipid metabolism at 11 % (Additional 437 
File 5). 438 
 439 
3.7.2 Gene expression by qPCR 440 
In liver, the expression of genes involved in sterol metabolism (apoB, cyp7a1) did not differ 441 
significantly between diets, although there was a trend for increased apoB expression with NP 442 
inclusion level (Table 11). Regarding genes involved in fatty acid and LC-PUFA metabolism, 443 
fads2d6a showed a significant decrease in fish fed diet L2 relative to fish fed diet L1, and diet L3 444 
intermediary to both. Expression of elovl2 was significantly higher in fish fed diet L2 than those fed 445 
diet L3, with diet L1 intermediary to both. Other genes (acc, elovl5, elovl6, fas) showed no significant 446 
effect of diet, although there was a trend for increased acc expression with increasing NP inclusion. 447 
Genes involved in 1-carbon metabolism (cbs, bhmt, mat1) and immune functions (il8, il1b) did not 448 
differ between fish fed the different diets. Finally, ghr expression was significantly higher in salmon 449 
fed diet L1 than those diet L2, with diet L3 intermediary to both.  450 
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In muscle, the expression of some genes involved in autophagy and protein turnover (atg12, 451 
gabarap, murf1a, mlp3b) showed significantly increased expression in salmon fed diet L3 relative to 452 
those fed diet L1, and diet L2 intermediary to both (Table 11). In addition, atg4b, and murf1b showed 453 
the same trend although differences between groups were not statistically significant. Differences 454 
between dietary groups for genes involved in growth and glucose transport (ghr, igf, glut4) were not 455 
significant. However, the pattern of ghr expression in muscle mirrored that of ghr in the liver, with 456 
fish fed diet L2 having lowest expression and those fed diet L1 highest, while igf expression showed 457 
a trend of increased expression with increasing NP inclusion. Finally, genes associated with immune 458 
function (il1bm) were not statistically different in muscle of post-smolt salmon. 459 
 460 
4. Discussion 461 
4.1 Growth 462 
In the current long-term study utilising S0+ Atlantic salmon parr, growth in freshwater and the pattern 463 
of final smolt body weight between diets mirrored that previously reported in S1+ Atlantic salmon 464 
parr fed the same diet formulation (Taylor et al., 2019). In both studies, fish fed diet L2 (2xNP) 465 
achieved a significantly higher final smolt weight, than fish fed diets L1 and L3, which was reflected 466 
in an improved growth rate (TGCbw) and more efficient FCR. In both studies, irrespective of smolt 467 
regime, diet L3 (4xNP) initially showed an increased growth rate relative to diet L1 (1xNP), but 468 
subsequently decreased, resulting in a final smolt weight intermediary to diets L1 and L2. This growth 469 
reduction occurred around 14 weeks post-feeding in the S1 salmon (Taylor et al., 2019) and within 4 470 
weeks of feeding under the S0+ regime in the current study. These results are in contrast to Hemre et 471 
al. (2016) and Prabhu et al. (2019), where parr were fed similar dietary formulations for 12 weeks but 472 
a decrease in growth rate beyond 2xNP was not observed. However, parr were not taken through parr-473 
smolt transformation (PST) in that short-term study. Of note, in both S1+ (Taylor et al., 2019) and 474 
the current S0+ parr study, the occurrence of growth reduction commenced at the start of the rising 475 
day length in spring (ambient in S1+; and following switch from LD 14:10 to LL in S0+). Given that 476 
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there are significant morphological, physiological and metabolic transformations during PST (Hoar, 477 
1988), then there may be differing dietary requirements and nutrient re-profiling during this transition. 478 
As such, the current study suggested certain components in NP could be in “excess” or detrimental 479 
to growth when supplemented at >2xNP levels, particularly in Atlantic salmon undergoing PST. 480 
However, both the current study and that of Taylor et al. (2019) have not been able to conclusively 481 
ascertain which components and/or interactions within the NP were detrimental, and further studies 482 
are clearly warranted to elucidate this apparent phenomenon.    483 
In seawater, growth rate (TGCbw) improved linearly with increasing NP, and bFCR was more 484 
efficient in fish fed diets L2 and L3 than L1, such that fish fed diet L3 while initially stocked at a 485 
significantly smaller body weight at smolt, attained a body weight comparable to that of fish fed diet 486 
L2 at harvest. By contrast, Hemre et al., (2016) did not find a strong effect of graded NP on growth 487 
rate in post-smolts, but this may in part be related to differences between the former and current study: 488 
shorter duration (5 months vs. 12 months), cooler water temperatures experienced (4.1-10 ˚C vs. 6-489 
16 ˚C) and subsequently lower TGCbw (2.37-2.55 vs. 2.9-3.1). Nonetheless, with the progressive 490 
reduction of FM and FO down to 5 % and 3 % during the current trial, results do confirm and support 491 
the earlier shorter-term studies (Hamre et al., 2016; Hemre et al., 2016; Taylor et al., 2019; Prabhu et 492 
al., 2019) that specific components of the NP are required to be supplemented at between 2x and 4x 493 
current recommendation when utilising high plant-based diets for the duration of the life cycle. The 494 
specific components of the NP that are associated with improvements in growth and performance will 495 
be discussed in subsequent nutrient status sections. 496 
 497 
4.2 Skeletal Health 498 
In contrast to growth, we observed a clear linear decrease in radiological deformity with increasing 499 
NP inclusion in freshwater which concurs with results from our previous short-term feeding study 500 
(Vera et al 2019). Further, in the current study, there was also a progression of spinal pathology in 501 
post-smolts when reassessed at harvest compared to initial smolt in fish fed diets L1 and L2, while 502 
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diet L3 showed no further increase in pathology. Concomitantly, spinal deformity was also inversely 503 
correlated with final whole body ash concentration, a widely accepted indicator of body/bone 504 
mineralisation (Baeverfjord et al., 2019), indicating increasing NP level improved post-smolt mineral 505 
status. Previously, upregulation of bone gene expression associated with extracellular matrix (ECM) 506 
mineralisation (ALP, Mgp, Ostcn), and corresponding decrease in skeletal pathology was observed 507 
following increased NP supplementation in parr (Vera et al., 2019). Effects were hypothesised to be 508 
mediated through altered P-Ca homeostasis pathways, as reflected by increased whole-body Ca:P 509 
ratios in smolts. Candidate components of the NP were suggested as vitamins D3 and K as cofactors 510 
of calcium sequestering. However, in the current study, improved mineralisation was not explained 511 
by differences in whole body macromineral concentration or retention in post-smolts which were 512 
similar across all diets and in the normal range for salmon (Shearer et al., 1994). Similarly, Fjelldal 513 
et al. (2009) reported a reduction in vertebral deformity at 4.1 kg in S0+ post-smolts fed a high mineral 514 
diet for the first 8 weeks post sea entry, and while analysis of plasma Ca, P and D-vitamin metabolites 515 
reflected changes in P homeostasis, these factors could not explain the preventive effect of a high 516 
mineral diet on development of bone deformities. To this end, given that analysed dietary vitamin D3 517 
and K in the current formulation were within established requirement ranges of 0.15-0.19 mg kg-1 518 
(NRC, 2011) and >0.1 mg kg-1 (Krossøy et al., 2009) respectively, it is unlikely these components of 519 
the NP are directly attributable to the graded decrease in spinal pathology observed in post-smolts, 520 
and other components of the NP are worth consideration.  521 
Whole body Zn and Se increased across diets with NP inclusion rate, with both being 522 
identified as the principal limiting micro-minerals in plant-based diets (Prabhu et al., 2018; Prabhu et 523 
al., 2019). Selenium is involved in antioxidant mechanisms and redox reactions in liver and blood 524 
cells, yet the role of Se in bone metabolism remains unexplored in salmonids to date (Baeverfjord et 525 
al., 2019). Recent studies have shown that Se, in the form of selenoproteins, plays a vital role in bone 526 
metabolism in humans (Pietschmann et al., 2014), with plasma selenoprotein P concentrations found 527 
to positively correlate with bone mineral density in elderly women (Zhang et al., 2014). As such, 528 
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although whole body Se levels across all diets were within the normal reported range for Atlantic 529 
salmon (Prabhu et al., 2016), the role of Se in teleost bone development should be investigated.  530 
It is well established that Zn is the most abundant micro-mineral in the vertebrae of many 531 
teleost fish species and has functional importance in the activity of ALP, and associated processes 532 
related to mineralisation of bone (Prabhu et al., 2016). Thus, improved Zn status and downstream 533 
processes may be directly attributable to the observed reduction in spinal pathology and progression 534 
as post-smolts, particularly in fish fed diet L3 (4xNP). While studies on spinal development have 535 
often focused on dietary macro- and micro-minerals, the role of specific vitamins within the NP 536 
should not be overlooked as having a beneficial effect on skeletal health. Whole body vitamin A 537 
levels suggested that diet L1 covered minimum requirement (>0.75mg kg-1 , Moren et al., 2004), and 538 
diet L3 had significantly lower skeletal deformity. Diet L1-L3 in this study contained 3.7-12.2mg 539 
kg-1 VA, well below the upper limits shown to induce skeletal pathology (>37 mg kg-1) (Ørnsrud 540 
et al., 2002; Ørnsrud et al., 2013). Therefore, it is unlikely that vitamin A deficiency or 541 
hypervitaminosis is attributable to the differences in spinal deformity rates observed. The specific 542 
role of B-vitamins on bone development in humans has been documented to a degree (Dai and Koh, 543 
2015) but, as yet, has not been investigated in fish (Lall & McCrea, 2007). Evidence from humans as 544 
reviewed by Dai and Koh (2015) has shown a variety of effects of vitamin B deficiencies including: 545 
reduced dietary intake of B6 is associated with lower bone mineral density; synthesis of methionine 546 
depends on both folate and B12 for remethylation, and deficiency of either B vitamin results in 547 
megaloblastic changes in bone marrow; B vitamin deficiency affects the anatomical/biochemical 548 
properties of bone if it is profound enough to cause hyperhomocysteinemia that is sufficient to induce 549 
an accumulation of homocysteine in the bone tissue. In light of the growing research in B vitamin 550 
involvement in bone metabolism in humans, greater consideration of B vitamin requirements in fish 551 
would also warrant consideration in relation to skeletal health. 552 
 553 
4.3 Protein and amino acid status and retention 554 
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The present study increased dietary taurine and histidine keeping the methionine constant in high 555 
plant protein diets for Atlantic salmon growing from parr to approximately 2.5 kg BW. NRC 556 
requirement for methionine in Atlantic salmon is reported to be 7 g kg-1 (NRC 2011). However, it 557 
was previously reported that dietary methionine of 7.9 vs 11.4 g kg-1 methionine improved growth 558 
and hepatosomatic index in salmon fed the latter diet (Espe et al., 2014). In another study, Atlantic 559 
salmon fed high plant protein diets containing either 8 or 11 g methionine per kg of diet, the weight 560 
gain in the latter diet did not differ from the control group fed a high fishmeal diet (760 g kg-1 diet). 561 
Thus, in the current trial it was decided to maintain the dietary methionine constant at around 9 g kg-562 
1 diet, while histidine and taurine were increased in the nutrient packages.   563 
The retention of amino acids is known to be high when an amino acid is slightly deficient and 564 
then decrease as the requirement for amino acid deposition is met or increased above requirement for 565 
protein deposition (Espe et al., 2017). In the current study this is also true for histidine, where 566 
retention decreased as dietary histidine increased. In addition to histidine, lysine retention was also 567 
reduced in salmon fed the L3 diet as compared to fish fed the L1 and L2 diets. Lysine is mainly used 568 
for protein deposition (Espe et al., 2007) and the reduced retention of lysine in fish fed the highest 569 
nutrient package thus might indicate a lower protein gain in muscle of these fish. However, as protein 570 
retention did not differ in fish fed any of the diets, reduced lysine retention does not seem to be 571 
associated with a reduced muscle protein deposition in the current trial. Thus, to address the reduced 572 
retention of lysine, interaction with other nutrients in the NP needs to be further explored. It is well 573 
known that both amino acid supply and the balance between dietary amino acids affect growth 574 
hormone, IGF and GH (Hevrøy et al., 2007; Bower et al., 2008; Valente et al., 2012). In the current 575 
trial these were not affected, which supports the fact that protein retention did not differ between fish 576 
fed any of the diets in the current trial.  577 
Any imbalanced supply of amino acids may increase the ubiquitination and thereby 578 
degradation of proteins (Bower et al., 2008; Valente et al., 2012). The gene expression level of murf, 579 
gabarab and atg12 were higher in the higher nutrient package in the current trial, but this is more 580 
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likely due to a higher degradation of soluble protein than the degradation of muscle protein. However, 581 
this also needs to be addressed in new trials using fewer variables.   582 
As expected, free histidine in muscle increased as dietary histidine increased simply reflecting 583 
the higher dietary histidine content in line with previous results (Remø et al., 2014). Taurine in muscle 584 
on the other hand did not increase following increased dietary taurine. This is most likely is due to 585 
increased excretion of excess taurine or that the taurine fed is directed to other tissues such as the 586 
liver (Espe et al., 2012a, 2012b). Both dietary histidine and taurine are more associated with oxidation 587 
and protection against ROS than with growth and metabolism (Remø et al., 2014) as well as survival 588 
of the cells (Espe and Holen, 2013), but these aspects were not addressed in the current trial. In 589 
addition, dietary taurine has been reported to reduce the visceral fat in salmon (Espe et al., 2012a, 590 
2012b), but as neither HSI nor VSI were affected by increased inclusion of NP, the L1 diet appears 591 
to contain sufficient taurine to not significantly affect adiposity in salmon in the current trial.   592 
Finally, free OH-proline decreased with increased nutrient package which might be due to an 593 
interaction with some of the other micronutrients fed, e.g. vitamin C. It is, however, unlikely that the 594 
lower OH-pro in fish muscle of fish fed the L3 diet is associated with any increased muscle 595 
degradation as deposition and growth actually was greatest in this group, although protein retention 596 
did not differ between the groups. 597 
 598 
4.4 Water-soluble vitamins 599 
Since growth was improved when increasing the nutrient package, without increasing methionine, 600 
the other components must have affected growth positively without the present level of methionine 601 
being critical, e.g. some of the B-vitamins will be critical for salmon to obtain maximum growth 602 
(Hemre et al., 2016), as well as some of the minerals (Prabhu et al., 2019a, b).  In an experiment with 603 
salmon parr, it was estimated that the 2xNP would cover requirement for several micronutrients, 604 
especially when given with high plant raw material diets (Hemre et al., 2016, Hamre et al., 2016, 605 
Prabhu et al., 2019a).  The present study, therefore, confirmed earlier conclusions that plant-based 606 
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diets need new requirement estimates for several micronutrients. The suggested body-concentrations, 607 
health outcomes and growth response used as requirement markers were not sufficient in the former 608 
study (Hemre et al., 2016), and the present study confirmed this.  609 
Pantothenic acid in whole body was higher in fish fed diets L2 and L3 compared to diet L1, 610 
while niacin increased gradually from L1 to L3, significantly at each step. Pantothenic acid in gill 611 
tissue also increased but differences were not significant. There was also a tendency for higher B6 612 
concentration in whole body in fish fed diets L2 and L3 compared to L1. This is in agreement with 613 
earlier findings for salmon post-smolt (Hemre et al., 2016). These results suggest that these three B-614 
vitamin optimal levels should be raised when compared to NRC (2011), to the 2xNP level for 615 
pantothenic acid and B6 and to the 4xNP level for niacin.  616 
Vitamin B6 interacts highly with protein metabolism (Hansen et al., 2015). Pyridoxine 617 
functions as phosphorylated coenzymes pyridoxal phosphate (PLP) in many reactions, such as 618 
transaminases in amino acid metabolism. Pyridoxine is a cofactor for the enzyme aromatic amino 619 
acid decarboxylase, which is required for the synthesis of neurotransmitters (Rorsman et al., 1995). 620 
Therefore, symptoms and consequences of vitamin B6 deficiency are many, diverse and severe, and 621 
include nervous disorders and abnormal behavior, none of which was registered in the present study.  622 
Tissues with mitochondria-rich cells and cells that undergo rapid cell divisions like gill tissue are 623 
especially sensitive to pantothenic acid deficiency. The 1xNP levels seemed to be sufficient for the 624 
other B vitamins (thiamine, riboflavin, folic acid and biotin), as found by Hemre et al. (2016). There 625 
was, however, a tendency for a decrease in retention of B-vitamins, significant only for riboflavin 626 
and folate. This may point to either an interaction and/or control factor at the gut-barrier level, or 627 
excretion of excess vitamin, since whole body levels were maintained or increased.   628 
Vitamin C in whole body increased from diet L1 to L2 and was then unchanged in fish fed 629 
diet L3. This is in accordance with previous results (Hamre et al., 2016). In the liver, changes in 630 
vitamin C concentrations were not significant (p = 0.06), but there was a tendency for an  increase in 631 
fish fed diet L2 compared to L1, and then a decrease in fish fed L3. The variation was very high in 632 
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both the L2 and L3 groups. It is well known that vitamin C may act as a pro-oxidant at high 633 
concentrations (Hamre et al., 1997), and this may indicate that diet L3, and perhaps L2, contained too 634 
much vitamin C, and an optimal vitamin C level at the 2xNP level or slightly less is needed. 635 
 636 
4.5 Lipid soluble vitamins 637 
Lipid soluble vitamins have a tendency to accumulate in the body in response to increased 638 
supplementation. Therefore, it is not possible to use body concentrations as an indication of 639 
requirement. This is true for α-tocopherol (TOH) which normally shows a linear relationship between 640 
supplementation and whole body concentration (Hamre et al., 1997; Hamre et al., 2016) as confirmed 641 
in the present study. Hamre et al. (2016) recommended supplementation with at least 150 mg kg-1 α-642 
TOH to compensate for variations in composition of feed ingredients and variation in oxidative stress, 643 
in response to handling, seasons and disease. TOH was not supplemented, but came from the feed 644 
ingredients, and the feed and whole body concentrations did not vary among the dietary treatments.  645 
For vitamin A, the situation is more complicated due to the presence of many different forms. 646 
Most of the vitamin A is present in the storage form retinol-esters (Moren et al., 2004), and the method 647 
used here determined esters and free forms combined. However, both free retinol and retinol esters 648 
increased exponentially with increasing concentration of vitamin A in the diet, and there was a large 649 
increase in body stores with an increase of dietary retinol equivalents from 0.75 to 2.5 mg kg-1 diet. 650 
Nevertheless, a requirement was found in Atlantic halibut of 2.5 mg kg-1 diet based on cell 651 
proliferation in the intestine as measured by DNA content, PCNA and maturity of the brush border 652 
membrane by enzyme activities (Moren et al., 2004). With reference to Moren et al. (2004) and the 653 
whole body levels found here, diet L1 had enough vitamin A (3.7mg kg-1) to cover the requirement 654 
(≥0.75 mg kg-1NRC, 2011). 655 
The diets were supplemented with the synthetic pro-vitamin K, menadione (vitamin K3). 656 
Menadione is very unstable during feed processing (Krossøy et al., 2009), and the analysed dietary 657 
levels of K3 were only 1/10 of the supplemented levels. Menadione is metabolised to menakinones 658 
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(MK4-13, vitamin K2) in the body (Krossøy et al., 2011) and therefore, MK4 increased in response 659 
to increase in dietary vitamin K3, while whole body vitamin K1 was similar in fish fed the different 660 
treatments. Krossøy et al. (2009) fed Atlantic salmon eight diets supplemented with 0 to 50 mg kg-1 661 
vitamin K3 and found no effects on fish performance, or blood coagulation time and vertebrae 662 
stiffness. They concluded that the feed ingredients probably contained enough vitamin K (0.1 mg kg-663 
1) to cover the requirement, which is consistent with the findings in the present study. Estimated 664 
requirements in other species range from 0.2 to 2 mg kg-1 (NRC 2011). 665 
Vitamin D was supplemented at 0.05, 0.10 and 0.20 mg kg-1, but the analysed levels in muscle 666 
were 0.15-0.19 mg kg-1, reflecting that the ingredients contained significant amounts of vitamin D3. 667 
Marine feed ingredients usually contain ample amounts of vitamin D and this may be the reason that 668 
vitamin D requirements in Atlantic salmon have been difficult to define. Furthermore, high doses of 669 
vitamin D up to 57 mg kg-1 seem to be well tolerated by Atlantic salmon (Horvli et al., 1998; Graff 670 
et al., 2002). In other fish species estimated requirements vary from 0.006 to 0.060 mg kg-1 (NRC 671 
2011), well below the supplementation levels in the present study.  672 
 673 
4.6 Minerals 674 
Optimal supply of dietary micro-minerals is essential to maintain body mineral homeostasis 675 
(Watanabe et al., 1997). Deficient or sub-optimal supply of dietary micro-minerals will deplete body 676 
mineral status, especially over the long term (Maage & Julshman, 1993). The NPs had graded levels 677 
of micro-minerals of which Zn and Se increased with increasing NP inclusions from diets L1 to L3. 678 
In plant-based salmonid feeds, Zn and Se have been identified as the most limiting micro-minerals 679 
(Prabhu et al., 2018, 2019a). In Atlantic salmon parr and post-smolt, dietary Zn levels of 101-132 mg 680 
kg-1 and 140-177 mg kg-1 respectively supplied by NP inclusion of 100-150 and 150-200 were able 681 
to meet the Zn requirement over the short-term (Prabhu et al., 2019a). Herein, on a long-term basis 682 
with an almost 30-fold increase in weight during the trial period, the L1 diet with 94 mg Zn kg-1 683 
decreased the Zn status to half and one-third in L2 and L3 fed-fish, respectively. Similar reductions 684 
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in whole body Zn ranging from 1/3 to ½ were observed in Atlantic salmon parr fed sub-optimal Zn 685 
levels (Maage & Julshman, 1993). The L2 diet with 156 mg Zn kg-1 was able to sustain the body Zn 686 
status on parr to the initial Zn status (18 mg kg-1 wet weight). However, the initial Zn status of the 687 
Atlantic salmon in this study was lower than values reported in the literature for similar size fish 688 
(Maage & Julshman, 1993; Shearer et al., 1994). The Zn status of Atlantic salmon fed the L2 diet (18 689 
mg kg-1 wet weight, averaging 2.3 kg) was considerably lower than the Zn status of 27-29 mg kg-1 of 690 
500 g post-smolt fed similar Zn levels in a previous trial (Prabhu et al. 2019a). Se levels in all three 691 
dietary groups were in the normal range observed in salmonids or Atlantic salmon specifically 692 
(Prabhu et al., 2016), mostly because the high background Se levels in basal diet already met the 693 
requirement. Although the NP composition did not change between the present and previous studies 694 
(Hamre et al., 2016; Prabhu et al., 2019a), the total dietary Se levels were considerably different for 695 
corresponding NP inclusions, thereby Se recommendations differ between studies. Variation in Se 696 
content of feed ingredients have to be considered in feed formulations and regulative legislation. The 697 
supplementation of manganese of 12 mg/kg diet in diet L1 corresponding to a total dietary Mn of 42 698 
mg/kg diet was sufficient to maintain normal body status. Recently, Prabhu et al. (2019b) also showed 699 
that Mn supplementation of 14 mg/kg as MnSO4 satisfied the minimal dietary requirement of Atlantic 700 
salmon post-smolt fed plant-based diets. The macro-mineral composition was within normal range 701 
and unaltered in Atlantic salmon fed the different diets implying the diets met the macro-mineral 702 
needs of Atlantic salmon over the entire study period. Overall, Atlantic salmon post-smolt in seawater 703 
were able to maintain their body status in the long run with minimal dietary supply of most micro-704 
minerals from the L1 diet, except for Zn which required L2 levels.  705 
 706 
4.7 Gene Expression 707 
In general, the number of significantly differentially regulated functional pathways were greater for 708 
the L3 vs. L1 dietary comparison, than for the L2 vs. L1 comparison. In fact, not only the number of 709 
up- or down-regulated pathways was higher in L3/L1, but also the number of DEGs involved in each 710 
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pathway was greater, suggesting a correlation between increased dietary micronutrient 711 
supplementation in low marine diets and changes in liver transcriptome. Regarding the effects on 712 
specific pathways, in both diet comparisons (L3/L1 and L2/L1), the terpenoid backbone and steroid 713 
biosynthesis pathways were down-regulated. A micronutrient dependent epigenetic gene regulation 714 
of the upstream regulator (acetyl-CoA carboxylase alpha, acaca) that provides malonyl-CoA 715 
substrate for the biosynthesis of fatty acids has been demonstrated (Saito et al, publication pending). 716 
The terpenoid backbone pathway underpins cholesterol (sterol), heme and vitamin (retinoids, retinol, 717 
retinoic acid, menadione) synthesis while both biosynthetic pathways are involved in steroid (e.g. 718 
testosterone) hormone production. The steroid and sterol biosynthetic pathways were also the most 719 
significantly affected in zebrafish offspring after feeding the parental generation a diet deficient in 720 
micronutrients (vitamin B12, vitamin B6, folic acid, methionine and choline) (Skjaerven et al., 2018). 721 
Further, the offspring from deficient parents had accumulated higher levels of lipid inclusion in the 722 
hepatocytes and showed a downregulation in the steroid biosynthetic process and widespread 723 
epigenetic changes of gene regulation in the liver (Skjaerven et al., 2018). This suggests that 724 
micronutrient supplementation may not only be affecting nutrient retention directly, but also via 725 
epigenetic mechanisms altering gene regulation and downstream biochemical process.  726 
These effects on gene expression may be in response to the increased supplementation of the 727 
L2 and L3 diets with cholesterol, menadione (vitamin K) and retinol (vitamin A) as part of the 728 
micronutrient premix and therefore reflect an increased requirement of these compounds in fish fed 729 
diet L1 (Kortner et al., 2014). The lower level of dietary pantothenic acid could also have affected 730 
the up-regulation of several metabolic pathways in fish fed diet L1. Pantothenic acid is required for 731 
synthesis of coenzyme A, which participates in a range of acyl transfer reactions in energy production, 732 
fatty acid oxidation, cholesterol and steroid synthesis, heme synthesis, amino acid catabolism, 733 
acetylcholine synthesis and many other acetylation and acylation reactions (Olsvik et al., 2013). 734 
Increased expression of genes related to glyoxylate/dicarboxylate metabolism was observed 735 
in salmon fed diet L1 in comparison to fish fed L3, suggesting lower levels of glucose in liver of L1 736 
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salmon and therefore the need to synthesise it from fatty acids. Meanwhile, an activation of 737 
intermediary metabolism in fish fed diet L3 may indicate higher levels of glucose available for energy 738 
production, and an enhancement of cellular energy levels as suggested by the increased number of 739 
up-regulated genes in glycolysis/gluconeogenesis, and oxidative phosphorylation pathways in fish 740 
fed diet L3. The differences in hepatic metabolic activities, energy generation and transport and 741 
growth performance between salmon fed diets L3 and L1 could be linked to the higher levels in L3 742 
fish of B vitamins (riboflavin, niacin), which are involved in a range of cellular processes, most 743 
importantly energy generation and transport that enables fish fed diet L3 to sustain vital metabolic 744 
processes without compromising the amount of energy available for growth (Hansen et al., 2015). 745 
The q-PCR results of genes involved in LC-PUFA biosynthesis showed down-regulation of 746 
biosynthesis with increasing micronutrient supplementation. A down-regulation of fads2d6a was 747 
found, indicating greater LC-PUFA biosynthesis capacity in the liver of L1 salmon. However, these 748 
differences were not fully reflected in hepatic n-3 LC-PUFA profiles in the present study, which 749 
showed no major differences between the dietary groups. In muscle, mlp3b, atg12 and gabarap genes 750 
were found to be upregulated in L3-fed salmon. These genes are involved in autophagosome mediated 751 
autophagy, playing an important role in autophagosome formation and sequestration of cytosolic 752 
cargo into double membrane vesicles, leading to subsequent degradation after fusion with lysosomes 753 
(Mannackand Lane, 2014). 754 
 755 
5. Conclusions 756 
The present study as part EU ARRAINA project,  confirmed earlier studies (Hamre et al., 2016; 757 
Hemre et al., 2016; Prahbu et al., 2019; Taylor et al., 2019; Vera et al., 2019) that plant-based diets 758 
for Atlantic salmon need new requirement estimates for several micronutrients. In particular, these 759 
optimal levels may differ between freshwater and seawater phases of the production cycle, and that 760 
requirements for growth and skeletal health may also differ. Based on the present results and 761 
conclusions from earlier studies (Hamre et al., 2016; Hemre et al., 2016; Prahbu et al., 2019a; Taylor 762 
31 
 
et al., 2019; Vera et al., 2019), NRC (2011) should be revised for diets in which plants form the major 763 
part of the ingredient mix. For these plant-based diets most B-vitamin optimal levels were met at the 764 
NRC (2011) recommendations, but beneficial effects were found with moderately increased levels 765 
(L2) of niacin, riboflavin and cobalamin, vitamin C, and the minerals Zn and Se. However, as 766 
indicated in all previous studies, too high levels of the micro-nutrient package (L3) may reduce these 767 
beneficial effects. 768 
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Figure Legends 976 
Figure 1. Evolution of growth (increase in weight) though freshwater and seawater phases of Atlantic 977 
salmon fed the three experimental diets (mean ± SD, n=3). The feeding period for each dietary 978 
formulation (% FM/FO) is shown in the blocks at the top of the figure. Superscripts denote significant 979 
differences between diets at each respective time point. 980 
 981 
Figure 2.  Percentage fish showing at least one or more radiological spinal deformities (≥+1dV) 982 
recorded at smolt (solid bars) and harvest (hatched bars) in the dietary treatments (25 fish per tank / 983 
pen, mean ± SD, n=3). Superscripts denote significant differences between life stage and diet 984 
(Kruskall-Wallis, p < 0.05). 985 
 986 
Figure 3. Functional categories of genes differentially expressed in liver of Atlantic salmon fed diets 987 
L2 (A) and L3 (B) compared to fish fed diet L1. Non-annotated genes and features corresponding to 988 
the same gene are not represented. 989 
 990 
Figure 4. KEGG pathway analysis of genes belonging to the metabolism category in liver of Atlantic 991 
salmon fed diets L2 (A) and L3 (B) compared to fish fed diet L1. Bars represent number of up- and 992 
down-regulated genes. Different colours indicate different nutrient groups. 993 
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Table 1. Formulation of the diets in terms of FM and FO inclusions used during the course of the 996 
study 997 
 998 
Pellet Size Fish Size L1 L2 L3   
2.0 mm 20-75g 
FM-15% FM-15% FM-15% 
FW 
FO-8% FO-8% FO-8% 
      
3.5 mm 75-250g 







FO-5% FO-5% FO-5% 
     
5.0 / 7.0 mm 250-1000g 
FM-10% FM-10% FM-10% 
FO-4% FO-4% FO-4% 
     
9.0 mm 1000-2500g 
FM-5% FM-5% FM-5% 
FO-3% FO-3% FO-3% 
 999 
  1000 
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Table 2. Raw material formulation (g.100g diet-1) and proximate composition (analysed) of 1001 
experimental diets. ARRAINA Nutrient Package and Amino Acid Premix inclusion for L1/L2/L3 1002 
diets respectively. 1003 
 MARINE PELLET SIZE (mm) 
INGREDIENTS 3.5 5.0 / 7.0 9.0 
Fish Meal1 13.00 8.00 3.00 
Krill Meal2 2.00 2.00 2.00 
Soy Protein Concentrate3 15.58 15.40 12.58 
Wheat Gluten4 12.46 13.09 10.70 
Maize Gluten 3.12 3.08 2.52 
Pea Protein Concentrate5 12.46 13.09 10.70 
Wheat6 17.86 10.00 13.33 
Sunflower Expeller - 6.32 6.77 
Fish Oil7 5.00 4.00 3.00 
Rapeseed oil4 7.65 10.61 16.17 
Linseed oil 1.91 2.55 3.84 
Palm kernel oil 4.78 6.38 9.61 
ARRAINA Nutrient Package8†‡  0.75 / 1.50 / 3.00 0.75 / 1.50 / 3.00 0.75 / 1.50 / 3.00 
Monosodium Phosphate 2.03 - - 
Monocalcium phosphate - 2.05 1.46 
Amino acid Premix9,* 2.14 / 2.34 / 2.32 2.07 / 2.11 / 2.16 2.15 / 2.18 / 2.24 
Yttrium 0.05 0.05 0.05 
Lucantin Pink 0.06 0.06 0.06 
Water change -1.98 -0.52 0.28 
 
Proximate Composition (Analysed) 
   
Moisture (%) 5.6 7.2 6.7 
Crude lipid (%) 24.6 25.7 31.5 
Crude protein (%) 43.8 41.4 41.2 
Ash (%) 6.0 5.3 5.3 
Energy (MJ / kg) 23.2 23.9 25.4 
1Feed Services, Bremen, Germany; 2Aker Biomarine, Norway; 3Caramuru, Brazil; 4Cargill, 1004 
Germany; 5Agrident, Germany; 6WN Lindsey, UK; 7ED & F Man, Germany; 8DSM, Netherlands; 1005 
9Evonik, Germany; †Added as components of the nutrient package (NP), and times requirement based 1006 
on NRC (2011) minimum requirement for Atlantic salmon and modified according to Hamre et al., 1007 
(2016), diet L1 achieving assumed 100 % minimum requirement; ‡ NP  *Balanced for lysine, 1008 
methionine, threonine and valine. Contains antioxidant. 1009 
 1010 
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Table 3. Analysed micronutrient contents (mg.kg-1) within the nutrient package (NP): selected 1012 
amino acids (histidine and taurine), minerals, vitamins and cholesterol. * Footnote denotes vitamin 1013 
and mineral sources. 1014 
  NP  
PREMIX INGREDIENTS 100% 200% 400% 
Vitamin A 3.79 7.58 15.16 
Vitamin D3 0.05 0.10 0.20 
Vitamin E 102.44 204.88 409.76 
Vitamin K3 9.82 19.64 39.28 
    
Thiamine 2.67 5.34 10.68 
Riboflavin 8.30 16.60 33.20 
B6 4.77 9.54 19.08 
B12 0.25 0.50 1.00 
Niacin 24.80 49.60 99.20 
Pantothenic Acid 17.15 34.30 68.60 
Folic Acid 2.82 5.64 11.28 
Biotin 0.14 0.28 0.56 
    
Vitamin C 80 160 320 
    
Calcium 0.4 0.8 1.6 
Cobalt 0.94 1.88 3.76 
Iodine 0.67 1.34 2.68 
Selenium 0.23 0.46 0.92 
Iron 32.64 65.28 130.56 
Manganese 12.03 24.06 48.12 
Copper 3.24 6.48 12.96 
Zinc 66.92 133.84 267.68 
    
Taurine 2450 4900 9800 
Histidine 1400 2800 5600 
    
Cholesterol 1100 2200 4400 
*Vitamin & Mineral Source: Vit A, Retinyl acetate; Vit D3, Cholecalciferol; Vit E, all-rac-alpha-tocopheryl acetate; 1015 
Vit K, menadione nicotinamide bisulphite; Thiamine, thiamine mononitrate; Riboflavin, Riboflavin; B6, Vitamin B6 / 1016 
pyridoxine hydrochloride; B12, cyanocobalamin; Niacin, nicotinic acid; Pantothenic acid, Calcium-D-pantothenate; 1017 
Folic acid, Folic acid; Biotin, Biotin; Vit C, L-ascorbic acid; Co: Cobalt carbonate; I, Calcium iodate anhydrous; Se, 1018 
Sodium selenite; Fe, ferrous sulphate monohydrate; Mn, Manganous oxide; Cu, Cupric sulphate pentahydrate; Zn, 1019 
Zinc oxide. 1020 
  1021 
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Table 4. Analysed concentrations of selected amino acids (taurine, histidine and methionine g.kg-1) 1022 
macro-minerals (calcium, magnesium and phosphorous, g.kg-1) micro-minerals and vitamins 1023 
(mg.kg-1) of the experimental diets. Nutrients added at graded levels to the feeds are shown with an 1024 
asterisk.  1025 
  DIET   
 L1 L2 L3 NRC 2011‡ 
Vitamin A* 3.7 5.2 12.2 0.75a 
Vitamin D3* 0.15 0.19 0.19 0.04a 
Vitamin E* 241.5 364.0 436.5 60b 
Vitamin K3* 0.71 1.51 2.70 <10b 
     
Thiamin* 4.5 7.1 8.8 1a, 
Riboflavin* 17.2 27.8 33.5 4a,  
Vitamin B6* 12.8 16.8 21.3 5b 
Vitamin B12* 0.18 0.35 0.67 NT 
Niacin* 73.0 112.0 148.0 10a,  
Pantothenic acid* 24.0 58.0 44.0 20a, 
Folic acid* 6.53 9.69 11.67 1a 
Biotin* 0.51 0.72 0.74 0.15a 
     
Vitamin C* 183.0 251.0 409.0 20b 
     
Cobalt* 0.18 0.22 0.32 NT 
Iodine* n.a n.a n.a 1.1a 
Selenium* 1.13 1.48 1.65 0.15a 
Iron* 330.0 358.0 403.0 30-60b 
Manganese* 42.0 53.0 86.0 10b 
Copper* 11.8 14.8 22.8 5b 
Zinc* 94.0 156.0 330.0 37b 
     
Taurine* 2.6 4.4 10.1 NRb 
Methionine 9.7 9.9 10.3 7.0b 
Histidine* 11.4 13.1 17.1 8.0b 
     
Calcium* 6.7 7.1 8.2 NRb* 
Magnesium 1.7 1.7 1.7 0.4b 
Phosphorus 12.7 12.5 12.5 8.0b 
     
Cholesterol* n.a n.a n.a NR 
‡Current NRC, 2011 minimum requirement recommendations determined in a rainbow trout, b 1026 
Atlantic salmon are shown for comparison. n.a. not analysed; NR* no requirement freshwater; NT, 1027 
not tested. 1028 
  1029 
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Table 5. Growth and morphometric indices recorded at the end of the fresh and seawater phases of 1030 
Atlantic salmon fed low marine ingredient diets (FM 15% / FO 8%) with differing micronutrient 1031 
supplementation levels (L1 = 100 %, L2 = 200 % and L3 = 400 % NRC Premix). Superscripts 1032 
denote significant differences between diets (mean ± SD, n=3, p < 0.05, one-way ANOVA)  1033 
 1034 
 DIET  
 L1 L2 L3 p values 
FRESHWATER     
Initial Parr Wt. (g) 38.2 ± 0.6 38.0 ± 0.6 38.1 ± 0.5 0.946 
Final Smolt Wt. (g) 68.0 ± 0.5c 77.4 ± 0.5a 73.8 ± 0.8b 0.0001 
Condition Factor (K) 1.29 ± 0.00c 1.19 ± 0.00b 1.18 ± 0.00a 0.0001 
TGCwt 1.29 ± 0.01
c 1.59 ± 0.01 a 1.48 ± 0.02b 0.0001 
bFCR 0.90 ± 0.01a 0.71 ± 0.01c 0.76 ± 0.01b 0.0001 
VSI (%) 8.23 ± 0.10 8.21 ± 0.18 8.44 ± 0.35 0.456 
HSI (%) 1.28 ± 0.06a 1.04 ± 0.01b 1.15 ± 0.06b 0.003 
Mortality (%) 0.2 ± 0.2 0.3 ± 0.1 0.0 ± 0.0 0.646 
SEAWATER     
Final Wt. (g) 2127.0 ± 59.0b 2381.0 ± 82.0a 2385.0 ± 37.0a 0.041 
Condition Factor (K) 1.37 ± 0.01b 1.43 ± 0.02ab 1.46 ± 0.03a 0.049 
TGCwt 2.87 ± 0.04
b 2.98 ± 0.05ab 3.02 ± 0.02a 0.045 
bFCR 1.11 ± 0.01a 1.08 ± 0.01b 1.08 ± 0.01b 0.049 
VSI (%) 8.66 ± 0.10 8.98 ± 0.11 8.75 ± 0.35 0.106 
HSI (%) 1.08 ± 0.06 1.02 ± 0.01 1.10 ± 0.04 0.426 
% Mortality 0.95 ± 0.76 2.64 ± 2.25 0.54 ± 0.13 0.594 
% Maturation 9.99 ± 1.64 5.94 ± 0.48 9.84 ± 0.74 0.063 
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Table 6. Protein, lipid, ash (g.kg-1 wet wt.), mineral content (mg.kg-1 wet wt.), retention (%) in 1037 
whole body, and protein, lipid and fatty acid composition (%) in muscle (Norwegian Quality Cut, 1038 
NQC) of Atlantic salmon at end of trial. Superscripts denote significant differences between diets 1039 
when variances were homogenous (mean ± SD, n=3, p<0.05, ANOVA), when non-homogenous 1040 
variances: (mean ± SD, n=3, p < 0.5, Kruskal-Wallis). 1041 
  DIET   
 L1 L2 L3 p values 
WHOLE BODY‡ 
Protein 16.6 ± 0.3 16.8 ± 0.2 16.6 ± 0.5 0.61 
Lipids 19.1 ± 1.4 20.0 ± 0.7 19.7 ± 0.8 0.59 
Ash 1.5 ± 0.11b 1.5 ± 0.11b 1.7 ± 0.11a 0.045 
Zn 9.0 ± 1.0c 18.0 ± 3.0b 29.0 ± 3.0a 0.0003 
Mn 1.5 ± 0.5 1.5 ± 0.3 1.3 ± 0.8 0.89 
Fe 7.1 ± 2.5 8.1 ± 0.4 8.9 ± 1.9 0.53 
Cu 2.7 ± 0.1 2.8 ± 0.2 2.8 ± 0.4 0.81 
Se 0.18 ± 0.01b 0.22 ± 0.02b 0.31 ± 0.02a 0.0003 
Mg 273.0 ± 15.0 273.0 ± 6.0 273.0 ± 15.0 1.00 
Ca 2500 ± 1000 2800 ± 400 2600 ±1700 0.50 
P 3000 ± 200 3400 ± 200 3400 ± 800 0.94 
WHOLE BODY RETENTION 
Protein 37.0 ± 1.0 37.0 ± 1.0 37.0 ± 2.0 0.63 
Lipids 62.0 ± 5.0 68.0 ± 2.0 67.0 ± 2.0 0.12 
Ash 28.0 ± 1.6 28.7 ± 1.3 29.1 ± 1.4 0.83 
Zn 8.3 ± 0.7 11.3 ± 2.2 7.7 ± 1.0 0.18 
Mn 2.8 ± 0.9 2.6 ± 0.6 1.3 ± 0.8 0.11 
Fe 1.8 ± 0.6 1.8 ± 0.1 2.0 ± 0.4 0.77 
Cu 19.7 ± 0.5a 16.9 ± 1.0ab 10.4 ± 1.5b 0.0001 
Se 12.5 ± 0.5b 12.2 ± 1.0b 17.9 ± 1.5a 0.001 
Mg 14.0 ± 1.0 14.9 ± 0.4 15.2 ± 1.1 0.29 
P 25.0 ± 7.0 26 ± 1.0 26.0 ± 6.0 1.00 
Ca 38.3 ± 23.0 33.4 ± 6.0 27.4 ± 19.0 0.92 
NQC 
Protein  19.8 ± 0.5 20.2 ± 0.6 20.0 ± 0.4 0.62 
Lipid  13.9 ± 0.3b 13.5 ± 0.1b 15.0 ± 0.5a 0.004 
Total PUFA 31.4 ± 0.4 31.4 ± 0.3 30.8 ± 0.2 0.40 
n-6 LC PUFA  17.5 ± 0.2a 17.1 ± 0.1ab 16.9 ± 0.1b 0.050 
n-3 LC PUFA  13.7 ± 0.2 14.0 ± 0.2 13.7 ± 0.1 0.45 
EPA  1.5 ± 0.00 1.6 ± 0.0 1.6 ± 0.0 0.056 
DHA  1.82 ± 0.05ab 1.90 ± 0.06a 1.60 ± 0.07b 0.036 
Total Carotenoid 4.27 ± 0.17 3.87 ± 0.29 3.96 ± 0.33 0.59 
‡Initial Body compositions at smolt sea transfer (L1 / L2 / L3): 1042 
Protein: (16.24±0.16 / 16.49±0.19 / 16.7±0.11); Lipids: (11.30±0.24 / 11.8±0.35 / 11.6±0.46); Ash: (2.23±0.12 / 1043 
2.25±0.14 / 2.15±0.07) ; Zn: (25±4.5 / 30±0.2 / 44±4.5); Mn: (2.2±0.2 / 2.1±0.6 / 1.9±0.4); Fe: (10±0.4 / 14±5.9 / 1044 
11±0.1); Cu: (1.2±0.1 / 1.4±0.1 / 1.5±0.1); Se: (0.29±0.01 / 0.32±0.02 / 0.37±0.02); Mg: (355±21 / 345±21 / 350±0); 1045 




Table 7. Amino acid retention (%) in Atlantic salmon fed the three plant-based diets. Superscripts 1048 
denote significant differences between diets (mean ± SD, n=3, p<0.05, ANOVA). 1049 
 1050 
  DIET   
 L1 L2 L3 p values 
His 31.2 ± 0.3a 30.2 ± 0.5a 26.8 ± 0.9b 0.005 
OH-pro 87.5 ± 10.7 75.6 ± 1.9 101.2 ± 18.8 0.41 
Arg 33.0 ± 0.4 33.4 ± 0.3 33.4 ± 1.4 0.94 
Ser 31.5 ± 0.3 32.2 ± 0.4 32.6 ± 1.1 0.61 
Gly 46.8 ± 1.1 44.4 ± 0.7 46.5 ± 2.6 0.56 
Asp 43.5 ± 1.1 44.1 ± 0.8 43.0 ± 1.0 0.74 
Glu 22.7 ± 0.2 22.8 ± 0.5 22.1 ± 0.9 0.71 
Thr 42.1 ± 0.2 43.0 ± 0.2 42.8 ± 1.1 0.68 
Ala 50.2 ± 1.1 50.6 ± 0.2 50.5 ± 1.4 0.95 
Pro 20.7 ± 0.4 20.4 ± 0.1 20.8 ± 0.9 0.86 
Tyr 36.6 ± 0.4 37.7 ± 0.3 36.4 ± 1.1 0.55 
Met 43.6 ± 0.3 44.9 ± 0.3 42.0 ± 1.6 0.19 
Lys 49.4 ± 1.4a 49.3 ± 0.4a 45.7 ± 0.2b 0.04 
Val 41.0 ± 0.5 41.7 ± 1.1 39.4 ± 0.7 0.18 
Ile 38.4 ± 0.5 39.2 ± 1.1 37.0 ± 0.6 0.21 
Leu 35.5 ± 0.1 36.0 ± 0.1 35.5 ± 0.6 0.53 
Phe 27.6 ± 0.3 28.5 ± 0.3 28.3 ± 1.2 0.71 
 1051 
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Table 8. Non-protein N metabolites in muscle (µmol.g-1 wet wt.). Superscripts denote significant 1054 
differences between diets (mean ± SD, n=3, p<0.05, ANOVA). 1055 
 1056 
  DIET   
 L1 L2 L3 p values 
Taurine 0.94 ± 0.01 1.13 ± 0.22 1.00 ± 0.02 0.58 
Urea 0.53 ± 0.02 0.52 ± 0.02 0.55 ± 0.06 0.88 
Asp 0.09 ± 0.00 0.10 ± 0.00 0.12 ± 0.00 0.15 
OH-pro 0.27 ± 0.02a 0.25 ± 0.01ab 0.16 ± 0.01b 0.03 
Thr 0.43 ± 0.02 0.40 ± 0.01 0.43 ± 0.02 0.62 
Ser 0.14 ± 0.01a 0.09 ± 0.01b 0.06 ± 0.01b 0.0005 
Glu 0.99 ± 0.06 0.93 ± 0.02 0.87 ± 0.11 0.51 
Gln 0.14 ± 0.02 0.23 ± 0.03 0.20 ± 0.02 0.08 
Sarcosine 0.08 ± 0.02 0.11 ± 0.02 0.09 ± 0.02 0.64 
Pro 0.53 ± 0.02 0.48 ± 0.06 0.29 ± 0.02 0.06 
Gly 2.37 ± 0.10a 1.46 ± 0.08b 0.98 ± 0.06c 0.0006 
Ala 2.83 ± 0.08 2.78 ± 0.11 2.47 ± 0.12 0.11 
Citruline 0.03 ± 0.01 0.03 ± 0.00 0.03 ± 0.00 0.79 
Alpha amino butyric acid 0.04 ± 0.00 0.05 ± 0.00 0.04 ± 0.00 0.22 
Val 0.28 ± 0.00 0.29 ± 0.01 0.29 ± 0.01 0.81 
Met 0.10 ± 0.00 0.11 ± 0.00 0.10 ± 0.00 0.18 
Cystathionine 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.42 
Ile 0.13 ± 0.00 0.14 ± 0.00 0.13 ± 0.00 0.73 
Leu 0.23 ± 0.01 0.25 ± 0.01 0.24 ± 0.01 0.30 
Tyr 0.17 ± 0.02 0.23 ± 0.03 0.18 ± 0.02 0.35 
Beta Ala 0.35 ± 0.02 0.39 ± 0.04 0.30 ± 0.01 0.10 
Phe 0.07 ± 0.00 0.09 ± 0.00 0.07 ± 0.00 0.05 
Ammonia 4.94 ± 0.15 4.80 ± 0.07 4.66 ± 0.05 0.22 
Ornithine 0.02 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.30 
Lys 0.81 ± 0.12 0.86 ± 0.04 0.95 ± 0.13 0.62 
1-methyl His 0.05 ± 0.00 0.06 ± 0.00 0.06 ± 0.01 0.42 
His 1.53 ± 0.20c 2.33 ± 0.07b 4.10 ± 0.09a 0.0001 
Anserine 26.58 ± 0.21 27.77 ± 0.20 27.46 ± 0.72 0.23 
Carnosine 0.37 ± 0.05 0.57 ± 0.08 0.42 ± 0.05 0.12 
Arg 0.16 ± 0.01 0.17 ± 0.00 0.18 ± 0.01 0.51 
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Table 9. Tissue concentrations (mg.kg-1 wet wt.) and retention (%) of water soluble vitamins. 1060 
Superscripts denote significant differences between diets when variances were homogenous (mean 1061 




  DIET   
 L1 L2 L3 p values 
WHOLE BODY     
Vitamin C 45.0 ± 4.0b 60.0 ± 6.0a 68.0 ± 5.0a   0.004 
Thiamin  1.2 ± 0.1 1.3 ± 0.1 1.2 ± 0.1 0.3 
Riboflavin 2.3 ± 0.1 2.4 ± 0.21 2.3 ± 0.2 0.57 
Pantothenic acid  9.3 ± 0.7b 12.0 ± 0.0a 12.3 ± 0.6a 6*10-4 
Niacin 32 ± 3c 46 ± 2b 56 ± 4a 4*10-4 
Folic acid 0.2 ± 0.0 0.3 ± 0.04 0.3 ± 0.02 0.25 
Biotin  0.1 ± 0.0 0.2 ± 0.2 0.1 ± 0.01 0.25 
Vitamin B6 0.3 ± 0.02 0.5 ± 0.03 0.5 ± 0.03 0.05 
LIVER     
Vitamin C 53.0 ± 1.0 91 ± 28 44 ± 24 0.06 
Biotin 2.8 ± 0.6 2.7 ± 0.5 3.1 ± 0.6 0.37 
Vitamin B12 0.6 ± 0.0 0.5 ± 0.1 0.6 ± 0.1 0.28 
Folic acid  16.8 ± 0.3 14.8 ± 1.2 15.9 ± 0.7 0.06 
Niacin 70.0 ± 3.0 72.0 ± 6.0 79.0 ± 12.0 0.42 
Riboflavine 12.7 ± 0.6 12.3 ± 0.6 12.3 ± 0.6 0.73 
GILL     
Pantothenic acid 8.5 ± 1.3 10.9 ± 1.9 12.0 ± 2.1 0.17 
MUSCLE     
Vitamin B6 5.8 ± 0.2 6.9 ± 0.8 6.9 ± 1.0 0.17 
RETENTION IN WHOLE BODY (%) 
Thiamin 21.2 ± 2.2 18.3 ± 1.0 18.6 ± 1.0 0.113 
Riboflavin 9.8 ± 0.1 7.1 ± 0.5 6.5 ± 0.5 0.051 
Niacin 37.4 ± 3.3 39.2 ± 2.8 33.1 ± 2.2 0.079 
Biotin 11.4 ± 0.0 9.0 ± 0.3 10.1 ± 1.5 0.148 
Folic acid 3.5 ± 0.1 2.3 ± 0.4 1.6 ± 0.1 0.027 
 1066 
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Table 10. Tissue concentrations (mg.kg-1 wet wt.) and retention (%) of lipid soluble vitamins. 1070 
Superscripts denote significant differences between diets when variances were homogenous 1071 




  DIET    
L1 L2 L3 p value 
WHOLE BODY     
Dry matter % 41.0 ± 1.0 40.0 ± 1.0 41.0 ± 1.0 0.40 
Vitamin A1   0.20 ± 0.16   0.58 ± 0.13   2.23 ± 0.42 0.04 
Vitamin A2    0.39 ± 0.06
c    0.83 ± 0.12b    1.77 ± 0.25a 0.0001 
Vitamin K (K1) 30.0 ± 6.0 32.0 ± 1.0 30.0 ± 0.0 0.25 
Vitamin K (MK4)  73.0 ± 6.0
b    84.0 ± 8.0 ab 100.0 ± 7.0a 0.008 
Vitamin E (α-TOH)  28.0 ± 5.0c   41.0 ± 5.0 b   57.0 ± 2.0a 0.0005 
Vitamin E (γ-TOH) 12.5 ± 3.8 12.1 ± 1.4  11.1 ± 0.5 0.56 
MUSCLE     
Vitamin D3   0.023 ± 0.006
c   0.030 ± 0.000b   0.043 ± 0.006a 0.01 
Vitamin E (α-TOH) 17 ± 2c 24 ± 1b 36 ± 3a 0.0001 
Vitamin E (γ -TOH)  9.9 ± 1.7  9.8 ± 0.8  9.2 ± 0.5 ns 
WHOLE BODY RETENTION 
Vitamin E (α-TOH)  8.8 ± 1.7a      9.2 ± 0.9ab  11.8 ± 0.6b 0.03 
Vitamin E (γ -TOH) 34.0 ± 10.0 30.0 ± 3.0 30.0 ± 1.0 0.60 
 1076 
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Table 11. Relative expression of diets L2 and L3 to L1 for genes involved in lipid and fatty acid 1079 
(FA) metabolism (liver) and protein turnover (muscle) in Atlantic salmon fed the experimental diets 1080 
(mean ± SEM, n=3). Superscripts denote significant differences between diets. 1081 
 1082 
  DIET   
GENE L1 L2 L3 p 
value 
LIPID AND FA METABOLISM (Liver)    
Apolipoprotein B-100 (apoB) 1.00 ± 0.09 1.68 ± 0.10 1.68 ± 0.31 0.890 
Acetyl-CoA carboxylase (acc) 1.00 ± 0.13 1.16 ± 0.22 1.23 ± 0.18 0.520 
Cholesterol 7 alpha-hydroxylase (Cyp7a1) 1.00 ± 0.40 0.64 ± 0.15 1.14 ± 0.55 0.572 
Fatty acyl elongase 2 (elovl2)   1.00 ± 
0.26ab 
 1.19 ± 0.20a  0.56 ± 0.15b 0.032 
Fatty acyl elongase 5 isoform b (elovl5) 1.00 ± 0.07 1.07 ± 0.14 0.84 ± 0.16 0.454 
Fatty acyl elongase 6 (elovl6) 1.00 ± 0.50 1.17 ± 0.78 0.91 ± 0.39 0.577 
Delta-6 fatty acyl desaturase isoform a (fads2d6a)  1.00 ± 0.34a  0.36 ± 0.09b   0.44 ± 
0.12ab 
0.035 
S-acyl fatty acid synthase thioesterase (fas) 1.00 ± 0.14 0.90 ± 0.09 1.00 ± 0.10 0.671 
1-CARBON METABOLISM (Liver)    
Cystathionine-β-synthase (cbs) 1.00 ± 0.26 0.91 ± 0.31 0.86 ± 0.26 0.854 
Betaine-homocysteine S-methyltransferase (bhmt) 1.00 ± 0.13 0.91 ± 0.13 1.09 ± 0.13 0.534 
Methionine adenosyltransferase1 (mat1) 1.00 ± 0.15 0.70 ± 0.15 1.10 ± 0.13 0.271 
Growth hormone receptor (ghr) 1.00 ± 0.40a  0.36 ± 0.11b   0.79 ± 
0.32ab 
0.043 
IMMUNE FUNCTION (Liver) 
Interleukin 8 (il8) 1.00 ± 0.20 0.74 ± 0.45 0.94 ± 0.17  0.640 
Interleukin 1 beta (il1b) 1.00 ± 0.20 1.10 ± 0.17 1.14 ± 0.12 0.663 
PROTEIN TURNOVER (Muscle)    
Autophagy-related protein 4 homolog B (atg4b) 1.00 ± 0.09 1.28 ± 0.20 1.24 ± 0.11 0.401 
Autophagy related  12 (atg12)  1.00 ± 0.08b   1.04 ± 0.05ab 1.29 ± 0.09a 0.029 
GABA(A) receptor-associated protein (gabarap)  1.00 ± 0.05b   1.24 ± 0.06ab 1.47 ± 0.09a 0.001 
Muscle-specific RING finger protein 1a (murf1a)  1.00 ± 0.04b   1.11 ± 0.17ab 1.19 ± 0.08a 0.049 
Muscle-specific RING finger protein 1b (murf1b) 1.00 ± 0.09 1.01 ± 0.18 1.51 ± 0.25 0.057 
Microtubule-associated proteins 1A/1B light chain 
3B precursor  (mlp3b) 
 1.00 ± 0.06b   1.20 ± 0.09ab 1.48 ± 0.07a 0.002 
GROWTH & GLUCOSE TRANSPORT (Muscle) 
Growth hormone receptor (ghr) 1.00 ± 0.12 0.73 ± 0.16 0.98 ± 0.15 0.427 
Insulin-like growth factor 1 (igf1) 1.00 ± 0.27 1.17 ± 0.33 1.43 ± 0.38 0.251 
Glucose transporter type 4 (glut4) 1.00 ± 0.06 0.95 ± 0.14 0.98 ± 0.09 0.824 
IMMUNE FUNCTION (Muscle)     
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